Radical redo surgery for local rectal cancer recurrence improves overall survival: A single center experience

Journal of Gastrointestinal Surgery

Volumn 12, Issue 7, 2008, Pages 1232-1238

  Schurr, Paulus ^a   Lentz, Edda ^a   Block, Suzette ^a   Kaifi, Jussuf ^a   Kleinhans, Helge ^a   Cataldegirmen, Guellue ^a   Kutup, Asad ^a   Schneider, Claus ^a   Strate, Tim ^a   Yekebas, Emre ^a   Izbicki, Jakob ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adenocarcinoma; Metastases; Rectal cancer; Recurrence; Total mesorectal excision

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; COLON RESECTION; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GERMANY; HUMAN; MALE; METHODOLOGY; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECTUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; COLECTOMY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 46249129135     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0517-8     Document Type: Article

References (29)

1. Tschmelitsch J, Kronberger P, Prommegger R, Reibenegger G, Glaser K, Bodner E. Survival and local recurrence after anterior resection and abdominoperineal excision for rectal cancer. Eur J Surg Oncol 1995;21(6):640-643 (December).
2. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-1740 (October 21).
3. Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in greater Amsterdam. J Surg Oncol 2007;95:447-454 (October 17).
4. Heald RJ. Local recurrence of rectal cancer. Dis Colon Rectum 1987;30(7):572 (July).
5. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638-646 (August 30).
6. Compton CC, Henson DE, Hutter RV, Sobin LH, Bowman HE. Updated protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Arch Pathol Lab Med 1997;121(12):1247-1254 (December).
7. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med 2000;124(7):1016-1025 (July).
8. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 2006;130(3):318-324 (March).
9. Dent OF, Haboubi N, Chapuis PH, Chan C, Lin BP, Wong SK et al. Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis 2007;9(2):112-121 (February).
10. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351(4):337-345 (July 22).
11. Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195(1):33-40 (July).
12. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39(3):323-328 (March).
13. Khera G, Walsh CJ, Anderson JA, El-Sayed TY, Haylock BJ, Myint AS et al. Local recurrence after curative resection for rectal cancer-role of the multi-disciplinary team. Colorectal Dis 2007;9(2):187 (February).
14. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099-1107 (August).
15. Swedish Rectal Cancer Trial. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 1996;162(5):397-402 (May).
16. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336(14):980-987 (April 3).
17. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638-646 (August 30).
18. Rodel C, Sauer R. Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer. Recent Results Cancer Res 2005;165:221-230.
19. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007;94(1):113-118 (January).
20. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-1740 (October 21).
21. Nagtegaal ID, van de Velde CJH, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23(36):9257-9264 (December 20).
22. Kapiteijn E, van de Velde CJH. Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002;38(7):919-936 (May).
23. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999;25(4):368-374 (August).
24. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, Dutch ColoRectal Cancer Group et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Eur J Surg 1999;165(5):410-420 (May).
25. Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJH. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome. Br J Surg 1998;85(1):92-97 (January).
26. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237(4):502-508 (April).
27. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099-1107 (August).
28. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr., Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60(9):2318-2324 (November 1).
29. Sigurdsson HK, Korner H, Dahl O, Skarstein A, Soreide JA. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study. Dis Colon Rectum 2007;50:285-288 (January 22).